SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-004270
Filing Date
2024-02-15
Accepted
2024-02-15 09:15:29
Documents
20
Period of Report
2024-02-15
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20240214c_8k.htm   iXBRL 8-K 26055
2 EXHIBIT 99.1 ex_626527.htm EX-99.1 34875
7 a01.jpg GRAPHIC 8294
8 a02.jpg GRAPHIC 5199
9 ex_626527img001.jpg GRAPHIC 30882
10 mbrx20240214c_8kimg001.jpg GRAPHIC 3327
  Complete submission text file 0001437749-24-004270.txt   271501

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20240215.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20240215_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20240215_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20240215_pre.xml EX-101.PRE 11584
21 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240214c_8k_htm.xml XML 2834
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 24642392
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)